FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566350009> ?p ?o ?g. }

• W2566350009 abstract "Abstract Background: Pulmonary Hypertension (PH) is a well-known complication of the advanced phase of Myeloproliferative Diseases (MPD) such as Polycythemia Vera (PV), Essential Thrombocytopenia (ET) and Myelofibrosis (MF). Although initially attributed to increased pulmonary vascular resistance (group 1 PH of the WHO classification), this entity was classified in 2009 in group 5 PH (unknown mechanism and miscellaneous PH). Our aim was to describe the prevalence and possible causes of PH in a series of patients with MF. Methods: We studied a series of patients with Primary MF or Secondary MF to other MPD with cardiac ultrasound, right heart catheterization and scintigraphy after intraarterial infusion of Tc99-labeled albumin macroaggregates. Results: We studied 11 consecutive patients with MF (7 male, mean age 58 years, 4 with MF post-PV, 4 post-TE and 3 Primary MF) during the period 2009-2014. All of them had mutations of JAK-2 gene, fibrosis in bone marrow biopsy and visceromegaly (all with intermediate-2 or higher IPSS). Median NTproBNP levels were 4597 pg/ml (range 175-5700). Echocardiogram showed high systolic pulmonary pressure in most cases, with a mean of 54 ± 17 mmHg (range 35-80). Right heart catheterization showed high cardiac output (HCO) in all patients (table 1). After ruling out other causes of HCO, a scintigraphy was performed after administration of Tc99-labeled albumin macroaggregates in descending thoracic aorta. In every case, a percentage of the labeled macroaggregates (6.1 ± 2.0% of the radioactivity) were plugged in the pulmonary capillary bed, what is diagnostic of the presence of microfistulas in infradiaphragmatic territory. In two of these patients, scintigraphies were performed at diagnosis and after been treated with the anti-JAK drug Ruxolitinib (Novartis Pharma). A favourable impact of this drug was obtained in the two cases, probably due to a reduction of spleen volume. Conclusion: Most patients with MF show pulmonary hypertension associated with high cardiac output caused by microfistulas, without significant increase in pulmonary resistance. This finding has important clinical implications, because pulmonary vasodilators (once recommended) should be contraindicated, since they could cause worsening of the clinical picture. Ruxolitinib could resolve PH in MF and a prospective study in this sense could be indicated. Table 1. Patient 1 2 3 4 5 6 7 8 9 10 11 Pulmonary Artery Pres. (S/D/Mean) 58/38/ 42 69/41/ 50 48/29/ 40 84/26/ 45 57/17/ 30 22/17 / 19 51/16 / 28 22/9 / 13 25/8 / 14 71/23 / 39 30/7 / 15 Pulmonary wedge pres. 28 37 27 13 9 7 13 7 8 12 6 Cardiac output (l/min) 12.5 8.0 11 7.1 8 7.3 8.7 6.7 7.45 6 7.8 Cardiac index (l/m/m2) 5.5 4.0 6.6 3.6 5 4 4.8 4.0 4.5 3.9 5.1 Pulmonary vascular resistance (Wood U.) 1.2 1.4 1.2 4.5 2.6 3 1.7 0.9 0.8 4.5 1.1 Disclosures Ojeda: Alexion Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Fores:Alexion Pharmaceuticals: Consultancy, Speakers Bureau." @default.
• W2566350009 created "2017-01-06" @default.
• W2566350009 creator A5016868599 @default.
• W2566350009 creator A5031897332 @default.
• W2566350009 creator A5046699862 @default.
• W2566350009 creator A5048380296 @default.
• W2566350009 creator A5048863162 @default.
• W2566350009 creator A5072416952 @default.
• W2566350009 creator A5083925677 @default.
• W2566350009 creator A5086408321 @default.
• W2566350009 date "2015-12-03" @default.
• W2566350009 modified "2023-10-17" @default.
• W2566350009 title "High Cardiac Output By Microfistulas: A New Pulmonary Hypertension Mechanism in Patients with Myelofibrosis and the Impact of the Treatment with Ruxolitinib" @default.
• W2566350009 doi "https://doi.org/10.1182/blood.v126.23.4065.4065" @default.
• W2566350009 hasPublicationYear "2015" @default.
• W2566350009 type Work @default.
• W2566350009 sameAs 2566350009 @default.
• W2566350009 citedByCount "0" @default.
• W2566350009 crossrefType "journal-article" @default.
• W2566350009 hasAuthorship W2566350009A5016868599 @default.
• W2566350009 hasAuthorship W2566350009A5031897332 @default.
• W2566350009 hasAuthorship W2566350009A5046699862 @default.
• W2566350009 hasAuthorship W2566350009A5048380296 @default.
• W2566350009 hasAuthorship W2566350009A5048863162 @default.
• W2566350009 hasAuthorship W2566350009A5072416952 @default.
• W2566350009 hasAuthorship W2566350009A5083925677 @default.
• W2566350009 hasAuthorship W2566350009A5086408321 @default.
• W2566350009 hasConcept C126322002 @default.
• W2566350009 hasConcept C141071460 @default.
• W2566350009 hasConcept C164705383 @default.
• W2566350009 hasConcept C2777385415 @default.
• W2566350009 hasConcept C2780007613 @default.
• W2566350009 hasConcept C2780076729 @default.
• W2566350009 hasConcept C2780930700 @default.
• W2566350009 hasConcept C71924100 @default.
• W2566350009 hasConcept C90924648 @default.
• W2566350009 hasConceptScore W2566350009C126322002 @default.
• W2566350009 hasConceptScore W2566350009C141071460 @default.
• W2566350009 hasConceptScore W2566350009C164705383 @default.
• W2566350009 hasConceptScore W2566350009C2777385415 @default.
• W2566350009 hasConceptScore W2566350009C2780007613 @default.
• W2566350009 hasConceptScore W2566350009C2780076729 @default.
• W2566350009 hasConceptScore W2566350009C2780930700 @default.
• W2566350009 hasConceptScore W2566350009C71924100 @default.
• W2566350009 hasConceptScore W2566350009C90924648 @default.
• W2566350009 hasLocation W25663500091 @default.
• W2566350009 hasOpenAccess W2566350009 @default.
• W2566350009 hasPrimaryLocation W25663500091 @default.
• W2566350009 hasRelatedWork W1484493657 @default.
• W2566350009 hasRelatedWork W1980735744 @default.
• W2566350009 hasRelatedWork W2000006816 @default.
• W2566350009 hasRelatedWork W2107082461 @default.
• W2566350009 hasRelatedWork W2127899831 @default.
• W2566350009 hasRelatedWork W2345563328 @default.
• W2566350009 hasRelatedWork W2354303708 @default.
• W2566350009 hasRelatedWork W2444142853 @default.
• W2566350009 hasRelatedWork W2556510367 @default.
• W2566350009 hasRelatedWork W2565186479 @default.
• W2566350009 hasRelatedWork W2889190883 @default.
• W2566350009 hasRelatedWork W2910247683 @default.
• W2566350009 hasRelatedWork W2920800853 @default.
• W2566350009 hasRelatedWork W2946495166 @default.
• W2566350009 hasRelatedWork W2978169054 @default.
• W2566350009 hasRelatedWork W2989843351 @default.
• W2566350009 hasRelatedWork W3031225962 @default.
• W2566350009 hasRelatedWork W3032274719 @default.
• W2566350009 hasRelatedWork W3121183047 @default.
• W2566350009 hasRelatedWork W9600690 @default.
• W2566350009 isParatext "false" @default.
• W2566350009 isRetracted "false" @default.
• W2566350009 magId "2566350009" @default.
• W2566350009 workType "article" @default.